- Home
- VATE vs SLS Comparison
VATE vs SLS Comparison
Compare VATE & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- SLS
- Stock Information
- Founded
- VATE 1994
- SLS 2012
- Country
- VATE United States
- SLS United States
- Employees
- VATE N/A
- SLS N/A
- Industry
- VATE Metal Fabrications
- SLS Biotechnology: Pharmaceutical Preparations
- Sector
- VATE Industrials
- SLS Health Care
- Exchange
- VATE Nasdaq
- SLS Nasdaq
- Market Cap
- VATE 82.6M
- SLS 75.3M
- IPO Year
- VATE 1996
- SLS N/A
- Fundamental
- Price
- VATE $4.28
- SLS $1.34
- Analyst Decision
- VATE
- SLS Buy
- Analyst Count
- VATE 0
- SLS 1
- Target Price
- VATE N/A
- SLS $3.00
- AVG Volume (30 Days)
- VATE 46.5K
- SLS 719.9K
- Earning Date
- VATE 11-06-2024
- SLS 11-13-2024
- Dividend Yield
- VATE N/A
- SLS N/A
- EPS Growth
- VATE N/A
- SLS N/A
- EPS
- VATE N/A
- SLS N/A
- Revenue
- VATE $1,231,500,000.00
- SLS N/A
- Revenue This Year
- VATE N/A
- SLS N/A
- Revenue Next Year
- VATE N/A
- SLS N/A
- P/E Ratio
- VATE N/A
- SLS N/A
- Revenue Growth
- VATE N/A
- SLS N/A
- 52 Week Low
- VATE $3.25
- SLS $0.50
- 52 Week High
- VATE $14.60
- SLS $1.72
- Technical
- Relative Strength Index (RSI)
- VATE 32.82
- SLS 54.24
- Support Level
- VATE $3.78
- SLS $1.07
- Resistance Level
- VATE $4.13
- SLS $1.39
- Average True Range (ATR)
- VATE 0.45
- SLS 0.07
- MACD
- VATE -0.28
- SLS 0.01
- Stochastic Oscillator
- VATE 7.73
- SLS 48.00
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting stations across the United States.
About SLS SELLAS Life Sciences Group Inc.
SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.